Christopher Aker - Sr. VP & General Counsel, Regulus Therapeutics Inc

As of May 17, 2021


Christopher Aker Net Worth

  • Net worth is estimated to be at least $43.85K
  • Owns at least 41,754 units of Regulus Therapeutics Inc stock
  • Sold an estimated value of $24.65K in the last 2 years at Regulus Therapeutics Inc

Christopher Aker Trading

  • Largest sale of shares was 6,950 units , worth over $9.8K on May 16, 2019
  • In total has made about 17 transactions over 2 years
  • Usually trades in February, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Christopher Aker Mailing Address

  • Mailing address is C/o Regulus Therapeutics Inc. 10614 Science Center Drive San Diego CA 92121 CA

Regulus Therapeutics Inc Insider Trading

  • The most recent transaction was 4,186 units sold on May 17, 2021 by Joseph Hagan worth over $3.73K
  • In the last 9 years, insiders at Regulus Therapeutics Inc sold an estimated value of $79.77M and bought an estimated value of $67.84M
  • The most active traders are Joseph Hagan, President and CEO,  Stelios Papadopoulos, Director,  and William Rastetter, Director
  • Insider trading is most common in June, with the busiest year in 2019

Regulus Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1